Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$400K Buy
50,429
+29,585
+142% +$256K 0.01% 677
2021
Q4
$195K Sell
20,844
-1,347
-6% -$16.2K 0.01% 1036
2021
Q3
$351K Buy
22,191
+2,222
+11% +$39.9K 0.01% 913
2021
Q2
$432K Sell
19,969
-1,023
-5% -$20.7K 0.01% 581
2021
Q1
$425K Buy
20,992
+853
+4% +$16.8K 0.02% 431
2020
Q4
$360K Buy
20,139
+2,079
+12% +$30.5K 0.01% 547
2020
Q3
$210K Buy
18,060
+979
+6% +$11.4K 0.01% 608
2020
Q2
$158K Sell
17,081
-1,171
-6% -$10.5K 0.01% 775
2020
Q1
$190K Buy
+18,252
New +$232K 0.01% 414

Other funds holding AXGN

IndexIQ Advisors's AXGN Position: Q1 2022 in Review

IndexIQ Advisors increased its Axogen (AXGN) stake by 142% in Q1 2022, buying an estimated $256K and bringing the position to 50,429 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #677.

IndexIQ Advisors first reported a position in AXGN in Q1 2020 and has held it in 9 quarters since. The position peaked at $432K in Q2 2021. 132 funds tracked by Wall St. Rank hold AXGN as of Q1 2022.

  • IndexIQ Advisors held 50,429 shares of Axogen worth $400K as of Q1 2022.
  • IndexIQ Advisors bought 29,585 Axogen shares in Q1 2022, an estimated $256K.
  • Axogen made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #677 holding.
  • IndexIQ Advisors first reported a position in Axogen in Q1 2020 and has held it in 9 quarters since.
  • IndexIQ Advisors's Axogen position peaked at $432K in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Axogen as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.